Given its ability to target the AKT/PTEN pathway, resveratrol holds promise as a therapeutic agent in glioblastoma treatment, its dual action of inhibiting tumor growth and reversing chemoresistance making it a valuable candidate for further research and clinical application [118,162,165]. This evidence concerns the gene AKT1 and glioblastoma.